Method for analyzing modified nucleoside

Patent metadata

Field	Value
Publication number	US-2025382669-A1
Application number	US-202218570878-A
Country	US
Kind code	A1
Filing date	Mar 30, 2022
Priority date	Jun 15, 2021
Publication date	Dec 18, 2025
Grant date	—

Abstract

An analyzing method includes: an elution step of introducing a sample containing a target component as a modified nucleoside having hydrophobicity increased by modification and a reference component as a component different from the target component into a column, and separating the target and reference components by gradient elution; a step of detecting the target and reference components by mass spectrometry; and a step of calculating a ratio between detection values of the target component and reference components. In the elution step, a mixing ratio of the solvents is changed such that between a first period in which the target component is eluted and a second period in which the reference component is eluted, a third period is provided in which a change rate of a mixing ratio at a column outlet is larger than that of a mixing ratio in each of the first and second periods.

First claim

1 . A method for analyzing a modified nucleoside, the method comprising:
an elution step of introducing a sample containing a target component as a modified nucleoside having hydrophobicity increased by modification and a reference component as a component different from the target component into a column for liquid chromatography, and separating the target component and the reference component from each other by gradient elution in which a mixing ratio of a plurality of solvents constituting a mobile phase is changed with time to elute from the column; a step of detecting each of the target component and the reference component by mass spectrometry; and a step of calculating a ratio between a detection value of the target component and a detection value of the reference component, wherein in the elution step, a mixing ratio of the solvents constituting the mobile phase to be introduced into the column is changed such that between a first period in which the target component is eluted from the column and a second period in which the reference component is eluted from the column, a third period is provided in which a change rate of a mixing ratio of the solvents constituting the mobile phase at an outlet of the column is larger than a change rate of a mixing ratio of the solvents constituting the mobile phase in each of the first period and the second period.

2 . The method for analyzing a modified nucleoside according to claim 1 , wherein the target component is a derivative of adenosine, is a modified nucleoside having a chemical structure in which threonine is bonded to the adenosine via a carbonyl group, and the reference component is a component not having the chemical structure.

3 . The method for analyzing a modified nucleoside according to claim 2 ,
wherein the target component is N 6 -threonylcarbamoyladenosine and/or 2-methylthio-N 6 -threonylcarbamoyladenosine, the method further comprising a step of comparing an obtained amount of the target component with at least one of an index value indicating possibility that a subject from which the sample is collected is suffering from COVID-19 and an index value indicating possibility that the subject suffers from COVID-19 and a condition becomes severe.

4 . The method for analyzing a modified nucleoside according to claim 1 , wherein
the sample is urine, and the reference component is at least one selected from the group consisting of creatinine, urea nitrogen, uric acid, adenosine, and 3-amino 3-carboxypropyluridine.

5 . The method for analyzing a modified nucleoside according to claim 1 , wherein
the sample is plasma or serum, and the reference component is at least one of adenosine and 3-amino 3-carboxypropyluridine.

6 . The method for analyzing a modified nucleoside according to claim 1 , wherein the mobile phase is a mixed solution of formic acid, acetonitrile, and water.

7 . The method for analyzing a modified nucleoside according to claim 1 , wherein the liquid chromatography is reverse phase chromatography.

8 . The method for analyzing a modified nucleoside according to claim 1 , comprising a washing step of washing the column using the mobile phase after the elution step, wherein
in the washing step, a mixing ratio of the solvents constituting the mobile phase to be introduced into the column is changed such that in an early stage or a late stage of the washing step, a fourth period is provided in which a change rate of a mixing ratio of the solvents constituting the mobile phase is larger than a change rate of a mixing ratio of the solvents constituting the mobile phase in each of the first period and the second period.

Assignees

• Shimadzu Corp
• Univ Kumamoto Nat Univ Corp
• Aisti Science Co Ltd

Inventors

• Kunisawa Akihiro
• Hattori Takanari
• Watanabe Jun
• Tomizawa Kazuhito
• Nagayoshi Yu
• Sasano Ryoichi
• Asai Tomoki

Classifications

• C12Q1/6872 Primary

  involving mass spectrometry · CPC title

• G01N33/569

  for microorganisms, e.g. protozoa, bacteria, viruses · CPC title

• G01N30/88

  Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 · CPC title

• G01N30/86

  Signal analysis · CPC title

• G01N30/72

  Mass spectrometers {(mass spectrometers per se H01J49/00)} · CPC title